DiaSense
PrivateLast Round
Grant
Mar 17, 2026
Total Funding Raised
$6.44M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
DiaSense operates in Frontier & Industrial Tech and is based in Copenhagen. Its latest recorded funding round was a Grant round in March 2026.
DiaSense is a deep-tech company that develops a Quantum Diamond Magnetic Microscope for advanced semiconductor failure analysis and production testing.
Sector
Frontier & Industrial Tech
Verticals
Semiconductors, Sensors, Quantum Computing
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DiaSense Comparables
Compare DiaSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quantum Diamonds | 92% | |
| EuQlid | 89% | |
| Quantum Catalyzer | 86% |
For institutional investors. Book with your work email.
DiaSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 17, 2026 | ||||
| Follow-on Offering | Mar 4, 2026 | ||||
| Accelerator | Feb 29, 2024 | ||||
| Grant | Jan 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DiaSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund Denmark | Grant |
| BioInnovation Institute | Accelerator, Follow-on Offering |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 1, 2026
Grew 33% QoQ, from 9 to 12 employees.
- Jul 1, 2025
Monthly visitors increased 580% MoM, reaching 415.
For institutional investors. Book with your work email.
DiaSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DiaSense's valuation, stock price, and market status.
Is DiaSense a public or private company?
DiaSense is a private company.
What is the current stock price of DiaSense?
DiaSense is a private company, so its shares have no public market price. Caplight tracks DiaSense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DiaSense worth (valuation)?
Valuation information for DiaSense is not publicly available.
Can I buy DiaSense stock?
DiaSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DiaSense's last funding round?
DiaSense's most recent funding round was Grant on March 17, 2026.
Who are the main investors in DiaSense?
Key investors in DiaSense include BioInnovation Institute.
Will DiaSense IPO soon?
No public IPO plans have been announced for DiaSense.
How can I track DiaSense secondary market activity?
Caplight tracks bids, offers, and trades in DiaSense's shares on secondary markets.